)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Oriola
Oriola (OKDBV) investor relations material
Oriola Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 earnings summary29 Oct, 2026
Executive summary
Q3 net sales rose 5.1% to EUR 53.0m; adjusted EBITDA was unchanged YoY at EUR 9.6m as growth was offset by a one-off EUR 0.7m inventory provision.
Commercial execution, operational improvements and higher volumes supported growth; supply-chain operations remained stable despite elevated inventories and capacity pressures.
9M adjusted EBITDA was EUR 25.3m; the period loss narrowed to EUR 1.3m from EUR 9.3m, while free cash flow turned negative amid working-capital outflows.
Financial highlights
Q3 invoicing increased 3.4% to EUR 1,053.6m; net sales grew 5.1% to EUR 53.0m.
9M invoicing rose 5.6% to EUR 3,263.8m; net sales increased 1.6% to EUR 158.9m, or 4.1% excluding Swedish dose dispensing sales in Q1 2025.
Q3 adjusted EBITDA was EUR 9.6m, flat YoY; reported EBITDA was EUR 6.1m versus EUR 7.0m, including EUR 3.5m of adjusting items.
9M EBITDA was EUR 15.3m versus EUR 14.5m; adjusted EBITDA was EUR 25.3m versus EUR 25.2m, including EUR 10.1m of adjusting items, mainly ERP costs.
9M result was EUR -1.3m versus EUR -9.3m and EPS was EUR -0.01 versus EUR -0.05; Q3 result was EUR 2.0m versus EUR 1.7m.
Outlook and guidance
FY 2026 adjusted EBITDA is expected to increase from EUR 35.1m in 2025; outlook was reiterated on the basis of market growth and strategy execution.
Sales growth is expected to continue in both segments; new distribution partnerships are expected to contribute positively from Q4.
Efficiency savings and cost control are expected to support profitability; distribution markets are forecast to grow, led by high-value medicines and products requiring advanced logistics.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Oriola
- Q2 2026 net sales up 1.7%, profitability steady, and adjusted EBITDA growth expected in 2026.OKDBV
Q2 2026 - Profitable growth, modernization, and sustainability drive long-term value and transparency.OKDBVCMD 2026
- Net sales up 10.7% to EUR 49.8m, adjusted EBITDA at EUR 7.7m, with major automation investments.OKDBVQ1 2026
- Net sales up 14% and adjusted EBITDA at EUR 35.1 million, but losses deepened on JV impairments.OKDBVQ4 2025
- Strong sales growth offset by ERP and Svensk dos costs, with improved EBITDA expected in 2025.OKDBVQ2 2025
- Q3 2024 net sales up 19% and adjusted EBIT up 25%, but profit remained negative.OKDBVQ3 2024
- Strong sales and EBIT growth, robust cash flow, and a positive 2024 outlook despite challenges.OKDBVQ2 2024
- Net sales up 19%, but profitability pressured by costs and impairment; EBITDA growth expected.OKDBVQ1 2025
- Net sales and EBIT grew, but goodwill impairment led to a loss; 2025 outlook remains positive.OKDBVQ4 2024
Next Oriola earnings date
Q4 202623 Feb, 2027
Oriola
Next Oriola earnings date
Q4 202623 Feb, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Oriola Oyj engages in providing healthcare and wellbeing products. It operates through the following segments: Consumer, Pharma and Retail. The Consumer business area offers products and services for health and
wellbeing for customers through Kronans Apotek, the third largest
pharmacy chain in Sweden.The Pharma business area provides advanced logistics, expert and advisory services for pharmaceutical companies, distributing a wide
range of pharmaceutical products for pharmacies, hospital pharmacies and veterinarians, and several other customer groups. The Retail business area offers a wide range of health and wellbeing
products to healthcare and retail operators, as well as services for
pharmacies, including staffing and dose-dispensing services. The company was founded in 1919. The headquarter is located in Espoo, Finland.